Molecure is a clinical stage biotechnology company that uses its world leading medicinal chemistry and biology capabilities to discover and develop first-in-class small molecule drug candidates that directly modulate the function of RNA and underexplored protein targets to treat multiple incurable diseases.
Our extensive in-house expertise has allowed us to collaborate with top global academic research institutes to access un...
Molecure is a clinical stage biotechnology company that uses its world leading medicinal chemistry and biology capabilities to discover and develop first-in-class small molecule drug candidates that directly modulate the function of RNA and underexplored protein targets to treat multiple incurable diseases.
Our extensive in-house expertise has allowed us to collaborate with top global academic research institutes to access untapped, novel biology targets.Our most advanced in-house drug candidate is OATD-02, an oral, potent and selective first-in-class, dual arginase inhibitor (ARG1 and ARG2) for the treatment of cancer.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.